Comprehensive T wave Morphology Assessment in a Randomized Clinical Study of Dofetilide, Quinidine, Ranolazine, and Verapamil. Issue 4 (13th April 2015)
- Record Type:
- Journal Article
- Title:
- Comprehensive T wave Morphology Assessment in a Randomized Clinical Study of Dofetilide, Quinidine, Ranolazine, and Verapamil. Issue 4 (13th April 2015)
- Main Title:
- Comprehensive T wave Morphology Assessment in a Randomized Clinical Study of Dofetilide, Quinidine, Ranolazine, and Verapamil
- Authors:
- Vicente, Jose
Johannesen, Lars
Mason, Jay W.
Crumb, William J.
Pueyo, Esther
Stockbridge, Norman
Strauss, David G. - Abstract:
- Abstract : Background: Congenital long QT syndrome type 2 (abnormal hERG potassium channel) patients can develop flat, asymmetric, and notched T waves. Similar observations have been made with a limited number of hERG‐blocking drugs. However, it is not known how additional calcium or late sodium block, that can decrease torsade risk, affects T wave morphology. Methods and Results: Twenty‐two healthy subjects received a single dose of a pure hERG blocker (dofetilide) and 3 drugs that also block calcium or sodium (quinidine, ranolazine, and verapamil) as part of a 5‐period, placebo‐controlled cross‐over trial. At pre‐dose and 15 time‐points post‐dose, ECGs and plasma drug concentration were assessed. Patch clamp experiments were performed to assess block of hERG, calcium (L‐type) and late sodium currents for each drug. Pure hERG block (dofetilide) and strong hERG block with lesser calcium and late sodium block (quinidine) caused substantial T wave morphology changes ( P <0.001). Strong late sodium current and hERG block (ranolazine) still caused T wave morphology changes ( P <0.01). Strong calcium and hERG block (verapamil) did not cause T wave morphology changes. At equivalent QTc prolongation, multichannel blockers (quinidine and ranolazine) caused equal or greater T wave morphology changes compared with pure hERG block (dofetilide). Conclusions: T wave morphology changes are directly related to amount of hERG block; however, with quinidine and ranolazine, multichannel blockAbstract : Background: Congenital long QT syndrome type 2 (abnormal hERG potassium channel) patients can develop flat, asymmetric, and notched T waves. Similar observations have been made with a limited number of hERG‐blocking drugs. However, it is not known how additional calcium or late sodium block, that can decrease torsade risk, affects T wave morphology. Methods and Results: Twenty‐two healthy subjects received a single dose of a pure hERG blocker (dofetilide) and 3 drugs that also block calcium or sodium (quinidine, ranolazine, and verapamil) as part of a 5‐period, placebo‐controlled cross‐over trial. At pre‐dose and 15 time‐points post‐dose, ECGs and plasma drug concentration were assessed. Patch clamp experiments were performed to assess block of hERG, calcium (L‐type) and late sodium currents for each drug. Pure hERG block (dofetilide) and strong hERG block with lesser calcium and late sodium block (quinidine) caused substantial T wave morphology changes ( P <0.001). Strong late sodium current and hERG block (ranolazine) still caused T wave morphology changes ( P <0.01). Strong calcium and hERG block (verapamil) did not cause T wave morphology changes. At equivalent QTc prolongation, multichannel blockers (quinidine and ranolazine) caused equal or greater T wave morphology changes compared with pure hERG block (dofetilide). Conclusions: T wave morphology changes are directly related to amount of hERG block; however, with quinidine and ranolazine, multichannel block did not prevent T wave morphology changes. A combined approach of assessing multiple ion channels, along with ECG intervals and T wave morphology may provide the greatest insight into drug‐ion channel interactions and torsade de pointes risk. Clinical Trial Registration: URL:http://clinicaltrials.gov/ Unique identifier: NCT01873950. … (more)
- Is Part Of:
- Journal of the American Heart Association. Volume 4:Issue 4(2015:Aug.)
- Journal:
- Journal of the American Heart Association
- Issue:
- Volume 4:Issue 4(2015:Aug.)
- Issue Display:
- Volume 4, Issue 4 (2015)
- Year:
- 2015
- Volume:
- 4
- Issue:
- 4
- Issue Sort Value:
- 2015-0004-0004-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2015-04-13
- Subjects:
- electrocardiography -- ion channels -- long‐QT syndrome -- pharmacology -- torsade de pointes
Heart -- Diseases -- Periodicals
Cardiovascular system -- Diseases -- Periodicals
Cerebrovascular disease -- Periodicals
Cardiology -- Periodicals
616.1 - Journal URLs:
- http://jaha.ahajournals.org ↗
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2047-9980 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1161/JAHA.114.001615 ↗
- Languages:
- English
- ISSNs:
- 2047-9980
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 8295.xml